Clinical Trial Update: SCH 727965 in Patients With Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia (P04717AM2)(TERMINATED) [Phase 2]

View source ↗

Summary

Phase 2 trial of SCH 727965 in patients with acute myeloid leukemia and acute lymphoblastic leukemia was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia

Drugs mentioned

• SCH 727965

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Leukemia, Myeloid, Acute, Lymphoblastic Leukemia, Acute | Phase 2 | Status: TERMINATED